Article Information
History
- March 27, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Arvind Pillai1,
- Kamen Bliznashki2,*,
- Emmette Hutchison2,
- Chanchal Kumar3,
- Benjamin Challis4 and
- Mishal Patel5
- 1Work performed while with Artificial Intelligence & Analytics, Data Science & Artificial Intelligence, R&D, AstraZeneca, Boston, US
- 2Human-centered AI & ML; Digital Health, Oncology R&D; AstraZeneca, Gaithersburg, US
- 3Work performed while with Translational Science & Experimental Medicine; Research and Early Development; Cardiovascular, Renal and Metabolism; BioPharmaceuticals R&D; AstraZeneca, Gothenburg, Sweden
- 4Translational Science & Experimental Medicine; Research and Early Development; Cardiovascular, Renal and Metabolism; BioPharmaceuticals R&D; AstraZeneca, Cambridge, UK
- 5Imaging Artificial Intelligence & Data Analytics; Clinical Pharmacology & Safety Sciences; Biopharmaceuticals R&D; AstraZeneca, Cambridge, UK
- ↵*Corresponding author: Kamen Bliznashki (kamen.bliznashki{at}astrazeneca.com)